De-crease Cancer is a 501(c)(3) organization based in Manalapan, New Jersey, registered in 2017, with $0 in FY2024 revenue. CharityIndex grades it C+.
Revenue (FY2024)
$0
Health median: $840K
Expenses (FY2024)
$31
Net assets
$3,555
Employees
—
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for De-crease Cancer— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For De-crease Cancer: 1376 mo reserves earns a B+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for De-crease Cancer— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For De-crease Cancer: 1 of 5 disclosure signals earns a D on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue declined from $500 (FY2017) to $0 (FY2024) across 8 reported years.
Financial snapshot
Total assets
$3,555
Net assets
$3,555
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $0▼100% | $31▼3.1% | $3,555▼0.9% | $3,555▼0.9% | 990EZ |
| 2023 | $26▼89.1% | $32 | $3,586▼0.2% | $3,586▼0.2% | 990EZ |
| 2022 | $238▼60.0% | — | $3,592▲7.1% | $3,592▲7.1% | 990EZ |
| 2021 | $595▼81.8% | $250▼77.0% | $3,354▲11.5% | $3,354▲11.5% | 990EZ |
| 2020 | $3,270▲3702% | $1,086 | $3,009▲265% | $3,009▲265% | 990EZ |
| 2019 | $86▼64.0% | — | $825▲11.6% | $825▲11.6% | 990EZ |
| 2018 | $239▼52.2% | — | $739▲47.8% | $739▲47.8% | 990EZ |
| 2017 | $500 | — | $500 | $500 | 990EZ |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Explore more
Data for De-crease Cancer (EIN 82-2548600) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.